{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T22:12:57Z","timestamp":1772057577443,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.eplepsyres.2010.07.011","type":"journal-article","created":{"date-parts":[[2010,8,15]],"date-time":"2010-08-15T04:42:25Z","timestamp":1281847345000},"page":"187-192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Effects of AEDs on biomarkers in people with epilepsy: CRP, HbA1c and eGFR"],"prefix":"10.1016","volume":"91","author":[{"given":"Alan W.C.","family":"Yuen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gail S.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet L.","family":"Peacock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias M.","family":"Koepp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip N.","family":"Patsalos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josemir W.","family":"Sander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2010.07.011_bib0005","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s004670000535","article-title":"Renal tubular dysfunction in epileptic children on valproic acid therapy","volume":"16","author":"Altunbasak","year":"2001","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.eplepsyres.2010.07.011_bib0010","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ejpn.2006.09.002","article-title":"Effect of sodium valproate monotherapy on serum uric acid concentrations in ambulatory epileptic children: a prospective long-term study","volume":"10","author":"Attilakos","year":"2006","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.eplepsyres.2010.07.011_bib0015","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000098053","article-title":"The effects of carbamazepine, valproic acid and phenobarbital on the oxidative and antioxidative balance in epileptic children","volume":"57","author":"Aycicek","year":"2007","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.eplepsyres.2010.07.011_bib0020","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/j.1552-4604.1982.tb02652.x","article-title":"Effects of single large doses of phenytoin on glucose homeostasis\u2013a preliminary report","volume":"22","author":"Banner","year":"1982","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2010.07.011_bib0025","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1093\/ndt\/gfl227","article-title":"Differences in decline in GFR with age between males and females. Reference data on clearances of inulin and PAH in potential kidney donors","volume":"21","author":"Berg","year":"2006","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.eplepsyres.2010.07.011_bib0030","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.eplepsyres.2007.07.005","article-title":"Cardiovascular risk factors and homocysteine in epilepsy","volume":"76","author":"Elliott","year":"2007","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2010.07.011_bib0035","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJM199902113400607","article-title":"Acute-phase proteins and other systemic responses to inflammation","volume":"340","author":"Gabay","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.eplepsyres.2010.07.011_bib0040","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0006-8993(99)02439-7","article-title":"Sodium valproate inhibits production of TNF-alpha and IL-6 and activation of NF-kappaB","volume":"857","author":"Ichiyama","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.eplepsyres.2010.07.011_bib0045","doi-asserted-by":"crossref","first-page":"413","DOI":"10.7326\/0003-4819-141-6-200409210-00006","article-title":"Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk","volume":"141","author":"Khaw","year":"2004","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.eplepsyres.2010.07.011_bib0050","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1373\/clinchem.2007.100271","article-title":"Prospective study of high-sensitivity C-reactive protein as a determinant of mortality: results from the MONICA\/KORA Augsburg Cohort Study, 1984\u20131998","volume":"54","author":"Koenig","year":"2008","journal-title":"Clin. Chem."},{"key":"10.1016\/j.eplepsyres.2010.07.011_bib0055","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/ana.70","article-title":"Mortality in epilepsy in the first 11 to 14 years after diagnosis: multivariate analysis of a long-term, prospective, population-based cohort","volume":"49","author":"Lhatoo","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.eplepsyres.2010.07.011_bib0060","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1373\/clinchem.2007.091959","article-title":"C-reactive protein and all-cause mortality in a large hospital-based cohort","volume":"54","author":"Marsik","year":"2008","journal-title":"Clin. Chem."},{"key":"10.1016\/j.eplepsyres.2010.07.011_bib0065","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1001\/archneur.1989.00520450051018","article-title":"Phenytoin-induced improvement in muscle cramping and insulin action in three patients with the syndrome of insulin resistance, acanthosis nigricans, and acral hypertrophy","volume":"46","author":"Minaker","year":"1989","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.eplepsyres.2010.07.011_bib0070","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/ana.21615","article-title":"Effects of antiepileptic drugs on lipids, homocysteine, and C-reactive protein","volume":"65","author":"Mintzer","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.eplepsyres.2010.07.011_bib0075","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1046\/j.1528-1157.2002.38701.x","article-title":"Epilepsy and mortality: a record linkage study in a U.K. population","volume":"43","author":"Morgan","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2010.07.011_bib0080","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/j.1528-1157.1997.tb01194.x","article-title":"Cause-specific mortality in epilepsy: a cohort study of more than 9,000 patients once hospitalized for epilepsy","volume":"38","author":"Nilsson","year":"1997","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2010.07.011_bib0085","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1365-2265.1980.tb01378.x","article-title":"The effect of long-term diphenylhydantoin therapy on glucose tolerance and insulin secretion: a controlled trial","volume":"12","author":"Perry-Keene","year":"1980","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"10.1016\/j.eplepsyres.2010.07.011_bib0090","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1111\/j.1528-1167.2009.02024.x","article-title":"Long-term antiepileptic drug therapy contributes to the acceleration of atherosclerosis","volume":"50","author":"Tan","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2010.07.011_bib0095","first-page":"423","article-title":"A different approach to analyzing age-related HbA1c values in non-diabetic subjects","volume":"42","author":"Vallee","year":"2004","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.eplepsyres.2010.07.011_bib0100","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/eurheartj\/ehl455","article-title":"The glomerular filtration rate in an apparently healthy population and its relation with cardiovascular mortality during 10 years","volume":"28","author":"Van","year":"2007","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.eplepsyres.2010.07.011_bib0105","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/ajcn\/74.1.130","article-title":"Plasma total homocysteine and cardiovascular and noncardiovascular mortality: the Hordaland homocysteine study","volume":"74","author":"Vollset","year":"2001","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.eplepsyres.2010.07.011_bib0110","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1046\/j.0306-5251.2001.01474.x","article-title":"In vitro evaluation of valproic acid as an inhibitor of human cytochrome P450 isoforms: preferential inhibition of cytochrome P450 2C9 (CYP2C9)","volume":"52","author":"Wen","year":"2001","journal-title":"Br. J. Clin. Pharmacol."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121110001981?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121110001981?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:24:08Z","timestamp":1760275448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121110001981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":22,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0920121110001981"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2010.07.011","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of AEDs on biomarkers in people with epilepsy: CRP, HbA1c and eGFR","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2010.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}